Remain Optimistic On Pharma, IT Cos: David Gaud
  • Elizabeth George
  • Oct 14 2013

October 14: Although valuations in pharma and IT space are high, we remain fairly positive on these sectors, says David Gaud, Senior Portfolio Manager at Edmond de Rothschild. There is more upside for these two sectors, he says, adding that funding costs and Indian banks remain a worry.